BNP Paribas Asset Management
TRML

BNP Paribas Asset Management’s Tourmaline Bio TRML Stock Holding History

BNP Paribas Asset Management’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-243
Closed -$12K – 2306
2025
Q3 		$12K Sell
243
-62
-20% -$1.72K ﹤0.01% 1581
2025
Q2 		$5K Buy
+305
New +$4.94K ﹤0.01% 2050

BNP Paribas Asset Management's TRML Position: Q4 2025 in Review

BNP Paribas Asset Management sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 243 shares — an estimated $12K sold.

BNP Paribas Asset Management first reported a position in TRML in Q2 2025 and held it in 2 quarters. The position peaked at $12K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

  • BNP Paribas Asset Management reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
  • BNP Paribas Asset Management sold 243 Tourmaline Bio shares in Q4 2025, an estimated $12K.
  • BNP Paribas Asset Management first reported a position in Tourmaline Bio in Q2 2025 and held it in 2 quarters.
  • BNP Paribas Asset Management's Tourmaline Bio position peaked at $12K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on BNP Paribas Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.